WIPO Re:Search was an international public-private consortium co-led by BVGH and the World Intellectual Property Organization (WIPO). Through the Consortium, BVGH catalyzed cross-sector, intellectual property-sharing R&D collaborations and capacity building fellowships to drive innovation for neglected tropical diseases, malaria, and tuberculosis.
After ten years, WIPO Re:Search came to a close at the end of 2022. See below for the program publication archives.
CLS Bulletin: Health Equity Spotlight
BIO Ventures for Global Health (BVGH) builds bridges across sectors and geographies to improve health equity for the world’s most vulnerable populations, in alignment with the priorities of those populations. Read More
The First 10 Years of WIPO Re:Search
Celebrating the first 10 years of WIPO Re:Search, now spanning over 40 countries. Read about the accomplishments of the partnership and its scientific network of over 150 members, which by sharing resources and expertise is collaborating to improve the global health landscape. Read More
US Chamber of Commerce’s Patrick Kilbride discusses the importance of WIPO Re:Search and explains why collaboration and innovation in research are the only way TB will experience a breakthrough in research. Read More
McGill Perspectives on Global Health
Canadian investigators partner through WIPO Re:Search to improve diagnosis of Chagas disease-a significant public health problem in Latin America. Read More
BVGH Accelerates R&D for Neglected Diseases through WIPO Re:Search Collaborations
BIO Ventures for Global Health (BVGH) today released its second compilation of WIPO Re:Search collaboration stories featuring partnerships accelerating neglected disease research. WIPO Re:Search, established by the World Intellectual Property Organization in partnership with BVGH and several leading pharmaceutical companies, brings scientists from academia and biopharmaceutical companies together to develop new therapies for diseases centered in developing nations. BVGH initiates these partnerships by identifying relevant research assets in pharmaceutical companies and matches them with academic researchers working on neglected tropical diseases. Read More
This publication celebrates collaborations facilitated by BVGH and their accomplishments. Read More
This publication highlights seven exciting drug development collaborations that are advancing solutions to some of the world’s most pernicious diseases. Each featured collaboration has achieved key R&D milestones and has been advanced and de-risked through WIPO Re:Search. Read More
TropMed Special Edition Book – Prospects for Schistosomiasis Elimination
The Journal of Tropical Medicine and Infectious Disease has published their special edition on schistosomiasis, featuring a BVGH peer-reviewed publication: “WIPO Re:Search—A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis.” Read More
TropMed Article: “WIPO Re:Search – Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development”
Through case studies, this article illustrates how WIPO Re:Search empowers high-quality tropical disease drug discovery researchers to leapfrog their R&D programs by accessing pharmaceutical industry resources. Read More
Schistosomiasis is an acute and chronic disease that affects over 200 million people worldwide, and with over 700 million people estimated to be at risk of contracting this disease, it is a pressing issue in global health. However, research and development (R&D) to develop new approaches to preventing, diagnosing, and treating schistosomiasis has been relatively limited. Read More
In 2010, the World Health Organization (WHO) classified a group of seventeen (17) bacterial, viral, and parasitic diseases as “neglected” because they lacked safe, effective, and affordable drugs, vaccines, and diagnostics to prevent, diagnose, and treat them. Globally, over one billion people are directly affected by these diseases. Read More
Pharmaceutical companies have deep expertise in the research and development (R&D) of new medicines and vaccines. In addition to conducting R&D in-house, they can accelerate R&D by sharing intellectual property (IP) assets with third-party researchers. Read More
WIPO Re:Search Strategic Plan 2017-2021
The World Intellectual Property Organization (WIPO), BIO Ventures for Global Health (BVGH) and the original 31 Members launched WIPO Re:Search with great ambition and more than a little hope in the fall of 2011. It is rare that one can honestly say that even one’s greatest expectations have been exceeded. Read More
WIPO Re:Search Partnership Stories 2013-2015
Since its launch in October 2011, WIPO Re:Search has exceeded our greatest expectations. We have made tremendous progress connecting researchers, facilitating collaborations, and advancing research and development in neglected tropical diseases, malaria, and tuberculosis. Members currently hail from 27 countries, with collaborations crossing oceans and spanning the globe. As of October 2015, BVGH has facilitated 95 agreements between WIPO Re:Search
members. Of the 95 agreements, 47 are ongoing and eight have met important development milestones. Read More
WIPO Re:Search Surpasses 50th Agreement
BVGH partner, the World Intellectual Property Organization, announced today in the press release below, that the WIPO Re:Search consortium has surpassed a major milestone in its fight against neglected diseases. Over 50 agreements between Consortium Members have been established to advance drug, vaccine, and diagnostic research and development for neglected tropical diseases, malaria, and tuberculosis. Read More
Interview with Joseph Hargan-Calvopiña (BIO Ventures for Global Health)
In this exclusive interview with Joseph Hargan-Calvopiña, learn more about the role played by BIO Ventures for Global Health (WA, USA) in drug development for malaria, tuberculosis and neglected tropical diseases and WIPO Re:Search, a consortium with the aim of advancing global research and development. Watch Here
In this exclusive interview with Joseph Hargan-Calvopiña, learn more about the role played by BIO Ventures for Global Health (WA, USA) in drug development for malaria, tuberculosis and neglected tropical diseases and WIPO Re:Search, a consortium with the aim of advancing global research and development. Read More
BVGH Presents WIPO Re:Search at Partnering For Cures Annual Conference
BIO Ventures for Global Health (BVGH), a nonprofit organization founded by the Biotechnology Industry Organization (BIO), announced today that President, Jennifer Dent is presenting BVGH programs at the annual Partnering for Cures meeting today, November 4th in New York City. The WIPO Re:Search Consortium aims to accelerate the development of new products to address the significant unmet medical needs of populations living in poverty and suffering from neglected diseases. Read More
WIPO Re:Search Partnership Stories 2012-2013
Recognizing the need for more progress in NTD research and product development, the World Intellectual Property Organization (WIPO) joined ranks with BIO entures for Global Health (BVGH), and several leading pharmaceutical companies to form WIPO Re:Search. The consortium’s objective is to establish partnerships that facilitate sharing of IP assets to advance the discovery and development of new drugs, vaccines, and diagnostics for NTDs, malaria, and tuberculosis. Read More